137 related articles for article (PubMed ID: 17048548)
1. Development of a novel vaccine delivery system based on Gantrez nanoparticles.
Gómez S; Gamazo C; San Roman B; Vauthier C; Ferrer M; Irachel JM
J Nanosci Nanotechnol; 2006; 6(9-10):3283-9. PubMed ID: 17048548
[TBL] [Abstract][Full Text] [Related]
2. Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis.
Gómez S; Gamazo C; San Roman B; Ferrer M; Sanz ML; Espuelas S; Irache JM
Eur J Pharm Biopharm; 2008 Nov; 70(3):711-7. PubMed ID: 18582571
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.
Salman HH; Gamazo C; de Smidt PC; Russell-Jones G; Irache JM
Pharm Res; 2008 Dec; 25(12):2859-68. PubMed ID: 18679774
[TBL] [Abstract][Full Text] [Related]
4. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
[TBL] [Abstract][Full Text] [Related]
5. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
6. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
[TBL] [Abstract][Full Text] [Related]
7. Bioadhesive mannosylated nanoparticles for oral drug delivery.
Salman HH; Gamazo C; Campanero MA; Irache JM
J Nanosci Nanotechnol; 2006; 6(9-10):3203-9. PubMed ID: 17048537
[TBL] [Abstract][Full Text] [Related]
8. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
9. Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens.
Gómez S; Gamazo C; Roman BS; Ferrer M; Sanz ML; Irache JM
Vaccine; 2007 Jul; 25(29):5263-71. PubMed ID: 17576025
[TBL] [Abstract][Full Text] [Related]
10. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
Gordon S; Saupe A; McBurney W; Rades T; Hook S
J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
[TBL] [Abstract][Full Text] [Related]
11. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.
Salman HH; Irache JM; Gamazo C
Vaccine; 2009 Jul; 27(35):4784-90. PubMed ID: 19539576
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy.
Pandey RS; Sahu S; Sudheesh MS; Madan J; Kumar M; Dixit VK
Int Immunopharmacol; 2011 Aug; 11(8):925-31. PubMed ID: 21333772
[TBL] [Abstract][Full Text] [Related]
13. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
Ebrahimian M; Hashemi M; Maleki M; Abnous K; Hashemitabar G; Ramezani M; Haghparast A
Int J Pharm; 2016 Dec; 515(1-2):708-720. PubMed ID: 27989827
[TBL] [Abstract][Full Text] [Related]
14. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice.
Chen N; Zhu P; Du T; Han K; Wang D; Ye J; Xiao S; Ye X; Wang Y
Pharm Res; 2018 Mar; 35(5):105. PubMed ID: 29560565
[TBL] [Abstract][Full Text] [Related]
16. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
[TBL] [Abstract][Full Text] [Related]
17. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
Slütter B; Jiskoot W
J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405
[TBL] [Abstract][Full Text] [Related]
18. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
19. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
[TBL] [Abstract][Full Text] [Related]
20. Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies.
Courant T; Bayon E; Reynaud-Dougier HL; Villiers C; Menneteau M; Marche PN; Navarro FP
Biomaterials; 2017 Aug; 136():29-42. PubMed ID: 28511142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
